Literature DB >> 8138065

The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects.

S E Kahn1, R L Prigeon, D K McCulloch, E J Boyko, R N Bergman, M W Schwartz, J L Neifing, W K Ward, J C Beard, J P Palmer.   

Abstract

Glucose disposal occurs by both insulin-independent and insulin-dependent mechanisms, the latter being determined by the interaction of insulin sensitivity and insulin secretion. To determine the role of insulin-independent and insulin-dependent factors in glucose tolerance, we performed intravenous glucose tolerance tests on 93 young healthy subjects (55 male, 38 female; 18-44 years of age; body mass index, 19.5-52.2 kg/m2). From these tests, we determined glucose tolerance as the glucose disappearance constant (Kg), calculated beta-cell function as the incremental insulin response to glucose for 19 min after an intravenous glucose bolus (IIR0-19), and derived an insulin sensitivity index (SI) and glucose effectiveness at basal insulin (SG) using the minimal model of glucose kinetics. To eliminate the effect of basal insulin on SG and estimate insulin-independent glucose uptake, we calculated glucose effectiveness at zero insulin (GEZI = SG - [SI x basal insulin]). Insulin-dependent glucose uptake was estimated as SI x IIR0-19, because the relationship between SI and beta-cell function has been shown to be hyperbolic. Using linear regression to determine the influence of these factors on glucose tolerance, we found that GEZI was significantly related to Kg (r = 0.70; P < 0.0001), suggesting a major contribution of insulin-independent glucose uptake to glucose disappearance. As expected, SI x IIR0-19 also correlated well with Kg (r = 0.74; P < 0.0001), confirming the importance of insulin-dependent glucose uptake to glucose tolerance. Although IIR0-19 alone correlated with Kg (r = 0.35; P = 0.0005), SI did not (r = 0.18; P > 0.08).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8138065     DOI: 10.2337/diab.43.4.587

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  29 in total

1.  Assessing the predictive accuracy of oral glucose effectiveness index using a calibration model.

Authors:  Michael Glicksman; Shivraj Grewal; Shrayus Sortur; Brent S Abel; Sungyoung Auh; Trudy R Gaillard; Kwame Osei; Ranganath Muniyappa
Journal:  Endocrine       Date:  2018-11-06       Impact factor: 3.633

2.  Hyperglycemia Promotes Schwann Cell De-differentiation and De-myelination via Sorbitol Accumulation and Igf1 Protein Down-regulation.

Authors:  Wu Hao; Syoichi Tashiro; Tomoka Hasegawa; Yuiko Sato; Tami Kobayashi; Toshimi Tando; Eri Katsuyama; Atsuhiro Fujie; Ryuichi Watanabe; Mayu Morita; Kana Miyamoto; Hideo Morioka; Masaya Nakamura; Morio Matsumoto; Norio Amizuka; Yoshiaki Toyama; Takeshi Miyamoto
Journal:  J Biol Chem       Date:  2015-05-21       Impact factor: 5.157

Review 3.  Considerations and guidelines for mouse metabolic phenotyping in diabetes research.

Authors:  Thierry Alquier; Vincent Poitout
Journal:  Diabetologia       Date:  2017-11-16       Impact factor: 10.122

4.  Glucose effectiveness, but not insulin sensitivity, is improved after short-term interval training in individuals with type 2 diabetes mellitus: a controlled, randomised, crossover trial.

Authors:  Kristian Karstoft; Margaret A Clark; Ida Jakobsen; Sine H Knudsen; Gerrit van Hall; Bente K Pedersen; Thomas P J Solomon
Journal:  Diabetologia       Date:  2017-08-25       Impact factor: 10.122

Review 5.  Exercise and Health-Related Risks of Physical Deconditioning After Spinal Cord Injury.

Authors:  Jennifer L Maher; David W McMillan; Mark S Nash
Journal:  Top Spinal Cord Inj Rehabil       Date:  2017

6.  Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.

Authors:  D A D'Alessio; S E Kahn; C R Leusner; J W Ensinck
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

7.  Glucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet.

Authors:  M Sörhede Winzell; C L Brand; N Wierup; U G Sidelmann; F Sundler; E Nishimura; B Ahrén
Journal:  Diabetologia       Date:  2007-05-04       Impact factor: 10.122

8.  Effects of endogenous androgens and abdominal fat distribution on the interrelationship between insulin and non-insulin-mediated glucose uptake in females.

Authors:  Uche Ezeh; Marita Pall; Ruchi Mathur; Damini Dey; Daniel Berman; Ida Y Chen; Daniel A Dumesic; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2013-02-28       Impact factor: 5.958

9.  Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism.

Authors:  J E Henriksen; F Alford; A Handberg; A Vaag; G M Ward; A Kalfas; H Beck-Nielsen
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

10.  Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome.

Authors:  Susan Sam; Yeon-Ah Sung; Richard S Legro; Andrea Dunaif
Journal:  Metabolism       Date:  2008-01       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.